Angiotensin receptor-neprilysin inhibitor delays progression from paroxysmal to persistent atrial fibrillation

Progression from paroxysmal to persistent atrial fibrillation (AF) is linked to adverse clinical outcomes. The present study sought to clarify whether angiotensin receptor-neprilysin inhibitor (ARNI) can delay AF progression. A retrospective cohort study was conducted on consecutive patients with pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Youzheng, Zhai, Zhenyu, Wang, Jihong, Xia, Zhen, Xia, Zirong, Zhu, Bo, Dong, Quanbing, Li, Qing, Li, Juxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950488/
https://www.ncbi.nlm.nih.gov/pubmed/36823222
http://dx.doi.org/10.1038/s41598-023-30349-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950488/
https://www.ncbi.nlm.nih.gov/pubmed/36823222
http://dx.doi.org/10.1038/s41598-023-30349-w

Ejemplares similares